1. Home
  2. NHS vs JCE Comparison

NHS vs JCE Comparison

Compare NHS & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHS
  • JCE
  • Stock Information
  • Founded
  • NHS 2003
  • JCE 2007
  • Country
  • NHS United States
  • JCE United States
  • Employees
  • NHS N/A
  • JCE N/A
  • Industry
  • NHS Trusts Except Educational Religious and Charitable
  • JCE Trusts Except Educational Religious and Charitable
  • Sector
  • NHS Finance
  • JCE Finance
  • Exchange
  • NHS Nasdaq
  • JCE Nasdaq
  • Market Cap
  • NHS 226.7M
  • JCE 266.3M
  • IPO Year
  • NHS N/A
  • JCE N/A
  • Fundamental
  • Price
  • NHS $7.48
  • JCE $15.87
  • Analyst Decision
  • NHS
  • JCE
  • Analyst Count
  • NHS 0
  • JCE 0
  • Target Price
  • NHS N/A
  • JCE N/A
  • AVG Volume (30 Days)
  • NHS 111.8K
  • JCE 49.7K
  • Earning Date
  • NHS 01-01-0001
  • JCE 01-01-0001
  • Dividend Yield
  • NHS 13.44%
  • JCE 9.26%
  • EPS Growth
  • NHS N/A
  • JCE N/A
  • EPS
  • NHS N/A
  • JCE N/A
  • Revenue
  • NHS N/A
  • JCE N/A
  • Revenue This Year
  • NHS N/A
  • JCE N/A
  • Revenue Next Year
  • NHS N/A
  • JCE N/A
  • P/E Ratio
  • NHS N/A
  • JCE N/A
  • Revenue Growth
  • NHS N/A
  • JCE N/A
  • 52 Week Low
  • NHS $6.95
  • JCE $11.64
  • 52 Week High
  • NHS $9.17
  • JCE $14.28
  • Technical
  • Relative Strength Index (RSI)
  • NHS 54.84
  • JCE 60.83
  • Support Level
  • NHS $7.14
  • JCE $15.51
  • Resistance Level
  • NHS $7.37
  • JCE $16.04
  • Average True Range (ATR)
  • NHS 0.12
  • JCE 0.25
  • MACD
  • NHS 0.01
  • JCE 0.04
  • Stochastic Oscillator
  • NHS 69.39
  • JCE 80.46

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest

Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.

Share on Social Networks: